Physician profile
Karen Singer
NPI 1417973264
$2,569.48
in general payments reported to CMS, 2019-2025
11 companies · $289 in 2025
The $289 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $808 · 2020: $225 · 2021: $404 · 2022: $473 · 2023: $288 · 2024: $82.39 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $659.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $659.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $932.72 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer |
| Merz North America, INC. | $731.66 | 2019 | |
| Innovation Technologies INC | $176.13 | 2022 | |
| Motiva USA, LLC | $160.28 | 2025 | |
| Abbvie INC. | $133.93 | 2023 | Natrelle Saline-Filled Breast Implants |
| Kci USA, INC. | $130.20 | 2020 | |
| Galderma Laboratories, L.P. | $114.60 | 2021-2023 | |
| Revance Therapeutics, INC. | $68.61 | 2025 | Daxxify |
| Astrazeneca Pharmaceuticals LP | $56.89 | 2019 | |
| United Therapeutics Corporation | $43.04 | 2021 | |
| Ardelyx, INC. | $21.42 | 2025 | Ibsrela |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karen Singer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.